[
    [
        {
            "time": "",
            "original_text": "疫苗接种黄金期，碧迪医疗与智飞生物签约",
            "features": {
                "keywords": [
                    "疫苗",
                    "接种",
                    "黄金期",
                    "碧迪医疗",
                    "智飞生物",
                    "签约"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "疫苗接种黄金期，碧迪医疗与智飞生物签约",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫苗概念股全线回撤，之江生物、东方生物跌逾15%",
            "features": {
                "keywords": [
                    "疫苗",
                    "概念股",
                    "回撤",
                    "之江生物",
                    "东方生物",
                    "跌逾15%"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗概念股全线回撤，之江生物、东方生物跌逾15%",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]